Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MET097 in Adults With Obesity or Overweight, and Type 2 Diabetes Mellitus
NCT06897202Phase 2Completed
- Sponsor
- Pfizer
- Start
- Mar 2025
- Primary completion
- Dec 2025
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of PF-08653944 in obesity, type 2 diabetes mellitus (T2DM), sponsored by Pfizer. Started Mar 2025; status: completed.
02
Drugs
PF-08653944
03
Conditions
obesitytype 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT06897202.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06897202.